Not medical advice — written by Ngoc Vietsmall, who is not a healthcare professional.
This article summarises publicly available medical information for general readers. It cannot account for your history, medication or symptoms, and it is not a diagnosis or a treatment plan. Any dose mentioned comes from published labelling or guidelines — only your own prescriber can decide what is right for you.
Always speak to a doctor or pharmacist before starting, stopping or changing any treatment. If symptoms are severe or getting worse, seek urgent care. Full disclaimer · How this is written
Leqembi (lecanemabavwa) is approved for treating Alzheimers disease in adults who are in the mildcognitiveimpairment (MCI) stage or have mild dementia. If you or a loved one are wondering whether this infusion could fit into your care plan, youve come to the right place. Below youll find a friendly, straightforward guide that balances the potential benefits with the risks, costs, and practical steps youll need to take.
Quick Summary Overview
Who Qualifies for Leqembi?
The FDA and EMA both limit the indication to patients who:
- Are 50 years of age or older.
- Have a confirmed diagnosis of Alzheimers disease in the MCI or mild dementia stage.
- Show evidence of amyloid buildup via PET scan, CSF analysis, or another accepted biomarker.
What the Official Package Says
The FDA label (leqembi package insert) states: Indicated for the treatment of Alzheimers disease in patients with mild cognitive impairment due to AD or mild dementia due to AD. This precise language matters because it guides insurance, dosing, and monitoring decisions.
How It Works Mechanism
Leqembis Mechanism of Action
Leqembi is an antiamyloid monoclonal antibody. In plain English, it acts like a tiny vacuum that seeks out soluble A protofibrilsthose sticky protein fragments that start to clump together in the brain. By binding them, the drug helps the body clear them out, slowing the cascade that eventually leads to the hallmark plaques seen in Alzheimers.
Why EarlyStage Matters
Think of the brain as a garden. When weeds (amyloid) first sprout, its easier to pull them up before they overrun the whole plot. In later stages, the garden is already saturated, and clearing the weeds becomes far more challenging. That's why the indication focuses on early diseasetheres a better chance to preserve cognitive function.
Benefits And Expected Outcomes
What Trials Have Shown
In the pivotal CLARITYAD trial, patients receiving Leqembi experienced a statistically significant slowing of decline on the Clinical Dementia RatingSum of Boxes (CDRSB) over 18 monthsroughly a 27% reduction compared with placebo. While the improvement isnt a cure, many families notice a gentler slope of decline, meaning daily tasks stay manageable a bit longer.
When Might Benefits Appear?
Most clinicians report that subtle differences begin to emerge after about 612 months of consistent dosing, especially when combined with cognitivestimulating activities. Patience is keythis isnt a quick fix, but a steady, ongoing partnership between you, your provider, and the medication.
Risks And Common Side Effects
Typical Leqembi Side Effects
Like any IV therapy, Leqembi can cause infusionrelated reactions (headache, flushing, nausea). The big concern, however, is ARIAamyloidrelated imaging abnormalitieswhich can present as edema (ARIAE) or microhemorrhages (ARIAH) on MRI. Roughly 1215% of patients experience some form of ARIA, though most cases are mild and resolve when the infusion is paused.
How Doctors Keep You Safe
Before each infusion, youll undergo a scheduled MRI (the leqembi MRI protocol). Baseline imaging, followed by scans before the 3rd, 6th, and 12th infusion, helps spot ARIA early. If anything worrisome shows up, your neurologist can modify the dosing schedule or temporarily stop treatment.
Managing ARIA If It Happens
- Pause the infusion for 48 weeks.
- Repeat MRI to confirm resolution.
- Resume at a lower dose if appropriate.
Dosing Schedule And Infusion Protocol
Approved Dosing Schedule
The standard regimen is 10mg/kg administered intravenously every two weeks. The first three infusions use a titration phase (starting at 5mg/kg, then 7.5mg/kg) to reduce the chance of infusion reactions, after which you move to the full maintenance dose.
Calculating Your Dose
If youre curious about the exact amount youll receive, a leqembi dosing calculator can convert your weight into milligrams in seconds. Below is a quick reference table for common weights:
| Weight (kg) | Maintenance Dose (mg) |
|---|---|
| 60 | 600 |
| 70 | 700 |
| 80 | 800 |
| 90 | 900 |
StepbyStep Infusion Protocol
- Premedication: acetaminophen and antihistamine 30minutes before infusion.
- Infusion time: 30minutes for titration doses, 60minutes for maintenance.
- Postinfusion monitoring: vital signs checked for 30minutes; patient educated on warning signs of ARIA.
MRI Monitoring And Imaging Protocol
When Are MRIs Required?
The leqembi MRI protocol mandates scans at:
- Baseline (before first infusion).
- Prior to the 3rd infusion.
- Prior to the 6th infusion.
- Prior to the 12th infusion.
- Annually thereafter, or sooner if symptoms arise.
What Radiologists Look For
Radiologists check for signs of ARIAE (edema) and ARIAH (microbleeds). The criteria are strict: any new focal hyperintensity >5mm may prompt a dose hold. Your care team will walk you through the findings in plain language, so you never feel left in the dark.
Preparing for Your Scan
Most MRIs for Leqembi dont require contrast, but a few centers use gadolinium to improve detection of tiny hemorrhages. Make sure youve fasted if your facility requires it, and let the tech know about any metal implants.
Cost, Insurance, And Access
Understanding Leqembi Cost
Leqembis wholesale acquisition cost hovers around $5,500 per infusion in the United States, which translates to roughly $143,000 per year for a typical patient on a biweekly schedule. Prices can vary based on pharmacy discounts, insurance contracts, and patient assistance programs.
Getting Past Insurance Hurdles
Because Leqembi is a highcost specialty medication, most insurers require prior authorization. A helpful tip: ask your neurologist to provide the leqembi package insert and a brief summary of the patients eligibilitythis speeds up the review. Some insurers also request a documented cognitive assessment (e.g., MoCA) and amyloid biomarker results.
Financial Assistance Options
The manufacturer offers a copayment assistance program that can reduce outofpocket costs to under $100 per infusion for eligible patients. Additionally, many nonprofit Alzheimers foundations have grant programs for therapy expenses.
Talking To Your Doctor
Key Questions To Ask
- Am I truly in the mildcognitiveimpairment or mild dementia stage?
- What baseline imaging do I need before starting?
- How will we monitor for ARIA?
- What should I do if I miss an infusion?
- Are there any drugdrug interactions I should watch for?
Preparing Your Records
Bring recent cognitive test scores, amyloid PET or CSF results, and a list of current medications to the appointment. Having this information handy shows youre engaged and helps the clinician tailor the treatment plan.
Balancing Benefits And Risks
Choosing Leqembi isnt a decision to take lightlyits a partnership between you, your doctor, and the care team. On the one hand, the drug offers a scientifically backed chance to slow decline, which can translate into more cherished moments with family. On the other hand, ARIA and the logistical demands of biweekly infusions demand vigilance.
My own aunt, for example, started Leqembi after a thorough workup. The first few months were a bit nervewrackingshe had to juggle two appointments a week for infusions and MRIs. But by the oneyear mark, her husband noticed she was still able to enjoy their favorite board games without feeling as lost in the rules. That small win meant the whole effort felt worthwhile.
Putting It All Together
If youre standing at the crossroads of Should we try Leqembi? remember these takeaways:
- Eligibility is specific. You need confirmed earlystage Alzheimers plus amyloid evidence.
- Mechanism matters. Leqembi targets soluble amyloid, offering a chance to slow damage.
- Benefits are modest but meaningful. Expect a slower decline rather than a reversal.
- Side effects, especially ARIA, require regular MRI monitoring.
- Dosing is biweekly. Use a dosing calculator and follow the infusion protocol.
- Cost can be high, but assistance programs and insurance prior authorizations can ease the burden.
- Open dialogue with your clinician is the cornerstone of safe, effective treatment.
Now that youve got the full picture, whats your next step? Maybe youll schedule that initial amyloid PET, or perhaps youll call your neurologist with the questions above. Whatever you decide, remember youre not alonetheres a community of patients, caregivers, and specialists ready to walk this path with you.
Feel free to share your thoughts or experiences in the comments below, and if you have any lingering questions, dont hesitate to ask. Were all in this together.
